Use of Monte Carlo simulation to assess the pharmacodynamics of β-lactams against pseudomonas aeruginosa infections in children: A report from the OPTAMA program-Reference-Cited by-同舟云学术

Use of Monte Carlo simulation to assess the pharmacodynamics of β-lactams against pseudomonas aeruginosa infections in children: A report from the OPTAMA program

Published:2005-11 Issue:11 Volume:27 Page:1820-1830
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Ellis Jennifer M,Kuti Joseph L.,Nicolau David P.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference42 articles.

1. Nosocomial infections in pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System;Richards;Pediatrics,1999

2. Prospective incidence study of nosocomial infections in a pediatric intensive care unit;Urrea;Pediatr Infect Dis J,2003

3. Nosocomial bloodstream infections in pediatric patients in United States hospitals: Epidemiology, clinical features and susceptibilities;Wisplinghoff;Pediatr Infect Dis J,2003

4. Rates of antimicrobial resistance among common bacterial pathogens causing respiratory, blood, urine, and skin and soft tissue infections in pediatric patients;Jones;Eur J Clin Microbiol Infect Dis,2004

5. Influence of patient age on the susceptibility patterns of Streptococcus pneumoniae isolates in North America (2000–2001): Report from the SENTRY Antimicrobial Surveillance Program;Jones;Diagn Microbiol Infect Dis,2003

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Measuring Creatinine Clearance Is the Most Accurate Way for Calculating the Proper Continuous Infusion Meropenem Dose for Empirical Treatment of Severe Gram-Negative Infections among Critically Ill Patients;Pharmaceutics;2023-02-07

2. Meropenem for the Pharmacological Treatment of Severe Infections in Critically Ill Pediatric Patients: Breakthrough Standard Treatment Strategies Based on PK/PD;Current Drug Metabolism;2023-01

3. Antimicrobial Stewardship in Pediatric Patients;Antimicrobial Stewardship in Non-Traditional Settings;2023

4. Relationship between Pharmacokinetic/Pharmacodynamic Target Attainment and Microbiological Outcome in Critically Ill COVID-19 Patients with Documented Gram-Negative Superinfections Treated with TDM-Guided Continuous-Infusion Meropenem;Pharmaceutics;2022-07-29

5. A Review of Extended and Continuous Infusion Beta-Lactams in Pediatric Patients;The Journal of Pediatric Pharmacology and Therapeutics;2022-03-01